Prot #BN42358: A Phase IIb, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants with Early Parkinson's Disease

Project: Research project

Project Details

StatusActive
Effective start/end date1/19/221/19/24

Funding

  • Genentech, Inc. (Agmt 01/19/22)